Spontaneous Murine Model of Anaplastic Thyroid Cancer
Journal of Visualized Experiments · 2023
DOI: 10.3791/64607 ↗Kurz gefasst
Video/Audio in der Zeitschrift Journal of Visualized Experiments, 2023. Verfasst von Huayun Yan und 8 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center. Hauptthemen laut MEDLINE: Thyroid Carcinoma, Anaplastic, Thyroid Neoplasms. Die Arbeit nennt 28 Literaturangaben.
Abstract (Originalsprache)
Anaplastic thyroid cancer (ATC) is a rare but lethal malignancy with a dismal prognosis. There is an urgent need for more in-depth research on the carcinogenesis and development of ATC, as well as therapeutic methods, since standard treatments are essentially depleted in ATC patients. However, low prevalence has hampered thorough clinical studies and the collection of tissue samples, so little progress has been achieved in creating effective treatments. We used genetic engineering to create a conditionally inducible ATC murine model (mATC) in a C57BL/6 background. The ATC murine model was genotyped by TPO-cre/ERT2; BrafCA/wt; Trp53ex2-10/ex2-10 and induced by intraperitoneal injection with tamoxifen. With the murine model, we investigated the tumor dynamics (tumor size ranged from 12.4 mm2 to 32.5 mm2 after 4 months of induction), survival (the median survival period was 130 days), and metastasis (lung metastases occurred in 91.6% of mice) curves and pathological features (characterized by Cd8, Foxp3, F4/80, Cd206, Ki67, and Caspase-3 immunohistochemical staining). The results indicated that spontaneous mATC possesses highly similar tumor dynamics and immunological microenvironment to human ATC tumors. In conclusion, with high similarity in pathophysiological features and unified genotypes, the mATC model resolved the shortage of clinical ATC tissue and sample heterogeneity to some extent. Therefore, it would facilitate the mechanism and translational studies of ATC and provide an approach to investigate the treatment potential of small molecular drugs and immunotherapy agents for ATC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center.
- Division of Thyroid Surgery, Laboratory of Thyroid and Parathyroid Disease, Frontiers Science Center for Disease-Related Molecular Network, Department of General Surgery, West China Hospital, Sichuan University.
- Department of Ultrasound, West China Hospital of Sichuan University, Sichuan University.
- Department of Otolaryngology-Head & Neck Surgery and University of Arizona Cancer Center, University of Arizona.
- Center for Translational Medicine, Shenzhen Bay Laboratory.
- State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center; Division of Laboratory Medicine/Research Centre of Clinical Laboratory Medicine, West Ch…
Zitieren
APA
Yan, H., Ma, Y., Zhou, X., He, Y., Liu, Y., Caulin, C., Wang, L., Xu, H., & Luo, H. (2023). Spontaneous Murine Model of Anaplastic Thyroid Cancer. Journal of Visualized Experiments. https://doi.org/10.3791/64607
Vancouver
Yan H, Ma Y, Zhou X, He Y, Liu Y, Caulin C, et al. Spontaneous Murine Model of Anaplastic Thyroid Cancer. Journal of Visualized Experiments. 2023. doi:10.3791/64607
BibTeX
@article{Yan2023,
author = {Yan, Huayun and Ma, Yingfang and Zhou, Xinyue and He, Yushuang and Liu, Yang and Caulin, Carlos and Wang, Leiming and Xu, Heng and Luo, Han},
title = {Spontaneous Murine Model of Anaplastic Thyroid Cancer},
journal = {Journal of Visualized Experiments},
year = {2023},
doi = {10.3791/64607}
}
EUVIMED